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We report a girl presenting with drug-refractory myoclonia
and generalized tonic-clonic seizure (GTCS) on awakening
who, initially, was misdiagnosed as having juvenile
myoclonus epilepsy (JME) before insulinoma was detected.
Many conditions may mimic or cause epileptic seizures,
including psychiatric and movement disorders, cardiac
arrhythmias and metabolic abnormalities. Toxic and meta-
bolic causes are potentially curable, are refractory to
antiepileptic drugs, and may be fatal if untreated. Insuli-
noma is a rare and treatable cause of hypoglycemic seizures
which might be misdiagnosed as intractable epilepsy.
Case report
In May 2001 a 13-year-old girl was referred to the hospital
because of GTCS on awakening. The family history was
unremarkable and her personal history revealed one simple
febrile seizure at age 3 years. One month before admission
two episodes of confusional states were reported which
lasted 5 and 30 min and were characterized by unrespon-
siveness and psychomotor slowing.
Physical and neurological examinations were normal,
weight was 62 kg (97th centile), height 162 cm (90th
centile), and menarche was at age 13 years (March 2001,
1 month before the first seizure). Awake EEG the day after
GTCS revealed normal background activity, bilateral
synchronous and asynchronous high-amplitude delta waves
over the parietotemporal regions, and right frontal sharp-
slow waves. Blood count, blood chemistry (glucose
4.5 mmol/l, calcium 2.4 mmol/l, potassium 4.0 mmol/l),
and magnetic resonance imaging (MRI) of the brain were
normal. Confusional states were interpreted as complex
partial seizures and GTCS as a secondary generalization.
Low-dose carbamazepine (6.3 mg/kg per day) was intro-
duced. Two weeks later, a second GTCS on awakening
occurred, followed by two short episodes of unresponsive-
ness before breakfast in front of the television. Another few
days later, perioral and eyelid myoclonus and jerks in the
arms and legs were noticed early in the morning. After
sleep deprivation a series of myoclonic jerks at awakening
in the morning and after several naps were registered
coinciding with generalized low-amplitude spikes or poly-
spikes. JME was diagnosed and carbamazepine replaced by
valproate (20 mg/kg per day) which was not effective. Blood
glucose was normal (4.2 mmol/l 4 h after food intake). Two
months later (August 2001) a second overnight long-term
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polyspikes and slow waves in the second part of the night.
Again myoclonic jerks in the hands and legs with a single
generalized low-amplitude spike and slow waves were
registered on awakening (Fig. 1).
In September 2001, 6 months after the manifestation of
the first seizures, low preprandial blood glucose (1.8 mmol/l,
normal 3.8–6.1) and high insulin (31 μU/ml, normal 1.9–
2.3) were detected because the patient was sluggish and
dizzy (glucose and insulin were measured by routine
methods). Inappropriate insulin secretion was suspected
and confirmed by pre- and postprandial glucose and insulin
measurements (preprandial: glucose 2.8 mmol/l, insulin
33 μU/ml and 50 min after food intake: glucose 3.1 mmol/l,
insulin 153 μU/ml); therefore, a 72-h fasting test was not
done. Abdominal ultrasound (US) and MRI revealed a round
and circumscribed hypoechoic lesion (2.1×1.8×1.9 cm)
with sharp butunevenborders inthepancreatic bodywithout
evidence of metastases. Insulinoma was suspected. Because
multiple endocrine neoplasia type I syndrome (MEN I) is
associated in 5–10% of the cases with insulinoma [5, 9],
prolactin, thyroid-stimulating hormone, parathyroid hor-
mone, and thyroxin (T3, T4) were determined, which were
all normal; therefore, mutation analysis of exons 2–10 of
the MENIN gene was not done. Valproate was stopped and
the patient was advised to have food intake every 2 h and
three times during the night. Since then she has been
seizure free, but myoclonic jerks recurred occasionally
when meals were delayed by >5 h during the night. Her
weight had increased from 62 to 84 kg within the last
10 months before surgery.
Surgery was performed 5 months later (March 2002) in
Moscow and two insulinomas were revealed by intra-
operative US: one located on the superior-posterior surface
between the head and body (diameter 2.5 cm) and the other
on the anterior surface of the pancreas (diameter 0.7–
0.9 cm). Before the surgery, US and MRI disclosed only
one lesion. Both insulinomas were removed in toto and the
endocrine pancreas was suppressed by Sandostatin (octreo-
tide) for 4 days. Histology confirmed the diagnosis of two
benign beta-cell adenomas. The patient fully recovered,
remained seizure free during the next 4 years, has a current
weight of 62 kg (75th centile), and is mentally normal.
Discussion
Myoclonus and GTCS after awakening are hallmarks of
JME, especially when adolescents are affected [2]. Hence,
in our patient the interpretation of the clinical symptoms
together with spike waves was indicative of JME. Confu-
sional states and drug-refractory seizures on the other side
are less compatible with the diagnosis of JME, but fit well
with hypoglycemic events. The latter, however, were
erroneously thought to be excluded by two normal blood
glucose measurements. Furthermore, hypoglycemia in
nondiabetic adolescents is much rarer than JME. Insuli-
noma, responsible for the profound hypoglycemia in our
patient, has its onset usually in middle [10] or older age [4]
Fig. 1 Ictal EEG on awakening:
generalized low-amplitude spike
with simultaneous registration of
myoclonic jerks of the hands
and legs. Although the EEG
pattern is not so typical for JME,
together with the history and the
clinical symptoms this EEG
seemed compatible with this
diagnosis
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following prolonged fasting states, especially in the
morning as in our patient, but also in the late afternoon
[4]. Hypoglycemia can cause loss of consciousness,
sluggishness, confusion, asthenia, deep coma, dizziness,
disturbances in vision, and epilepsy. An international
review of 1,067 cases [10] showed such neuropsychiatric
symptoms in 92% of the patients. Irreversible damage of
the central nervous system occurred in 6.8% of the cases
[10]. Forty-one percent of the patients have amnesia during
the hypoglycemic event [4]. Therefore, the history has to be
obtained from family members or friends. Clinical details
about the onset, duration, and type of symptoms as well as
temporal association with fasting and the relief of symp-
toms after food intake are helpful information for making
the diagnosis. Considerable weight gain as in our patient
was reported in 39% of the patients [4]. Taking into account
that an actually normal glucose level does not exclude
episodes of hypoglycemia, a prolonged fasting test up to
72 h under close monitoring is recommended to assess
inappropriate insulin secretion [3].
The median interval from the onset of symptoms to the
diagnoses of insulinoma is 2 years, with a wide range of
1 month to 30 years [4]. Initial misdiagnosis is frequent. In
a series of 59 patients with insulinoma, prior diagnosis
included neurological disorders in 39 (64%) and especially
epilepsy in 23 (39%) patients. Seven patients (12%) were
treated with antiepileptic drugs [4]. The seizure symptoms
are variable. During severe hypoglycemia generalized and
focal seizures occurred in children [6]. In patients with
insulinoma, shaking of all four limbs at night [8], jerking
and twitching [1], and symptoms suspicious for partial and
complex partial seizures with and without secondarily
generalized seizures are reported [3, 5]. Varying degrees
of EEG changes and sometimes massive spiking were
recorded during hypoglycemia [7]. In patients with insuli-
noma, focal and widespread EEG slowing [1, 3] combined
with epileptic activity [5] are mentioned.
Conclusions
The combination of seizures and episodic confusional states
should prompt the search for hyperinsulinism, especially
when the episodes occur in fasting states and when they are
refractory to antiepileptic treatment. Inappropriately high
insulin with low blood glucose is diagnostic; this constel-
lation has to be investigated resolutely (e.g., by the classic
72-h fasting test) but with caution under strict clinical and
chemical monitoring. Timely diagnosis of an insulinoma is
of paramount importance to prevent sequelae for such
patients.
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